iDSI Vietnam Story
In 2013, HIU received a request from the Rockefeller Foundation, to support the development of UHC in Vietnam. Since then, the Vietnam engagement has moved under the umbrella of iDSI projects. The Health Strategy and Policy Institute (HSPI), was appointed by the Ministry of Health to be the country focal point on HTA. As […]
READ MORE
Establishment of the Medical Technology Assessment Board (MTAB): Initiating Health Technology Assessment (HTA) in India
Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in collaboration with the country and international partners and is part of the […]
READ MORE
Same same but different
I (the author of the blog) got to learn a lot about three things while discussions on these potential topics were on-going. Firstly, I got to know the uniqueness of the Vietnamese Health System and how they are trying to incorporate HTA and pharmacoeconomics in their current system, secondly I learned a lot more about […]
READ MORE
6th HTAsiaLink Conference 2017 Hanoi, Vietnam
This year’s conference was held at La Than Hotel in Hanoi, Vietnam from 17th to 19th April 2017 organized by Health Strategy and Planning Institute (HSPI), Ministry of Health, Vietnam. Around 120 participants attended the conference. The theme this year was ‘Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage (UHC)’. […]
READ MORE
Universal Health Compassion for Universal Health Coverage
Jakarta: As we fly over the clear blue Java Sea, I notice the sand from a few scattered islands sloping into the clear waters. I glance again towards my right shoulder at the travel pack I have been reading, containing Indonesia’s country progress report and the objectives of our collaborative activities. I am part of […]
READ MORE
Considering the inclusion of off-label medicines in UHC package of Indonesia
In the global scheme of medicines provision, low- and middle-income countries (LMICs) face difficulties in ensuring medicine access. Aside from the improvements still needed to healthcare infrastructure, financing, and service delivery, these countries also face issues in prioritizing their health services and ensuring the sustainability of their benefits packages. These issues are complex, but even […]
READ MORE